Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema (left eye)
ICD-10 E10.3592 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema (left eye).
E10.3592 refers to Type 1 diabetes mellitus characterized by the presence of proliferative diabetic retinopathy (PDR) in the left eye without associated macular edema. Proliferative diabetic retinopathy is a severe form of diabetic eye disease where new, abnormal blood vessels grow on the retina, which can lead to vision loss. This condition arises due to chronic hyperglycemia, which damages the retinal blood vessels. In patients with Type 1 diabetes, the onset of PDR typically occurs after several years of diabetes, often when HbA1c levels are poorly controlled. Management of this condition involves regular ophthalmologic examinations, strict glycemic control, and may include laser photocoagulation therapy to prevent further vision loss. The absence of macular edema indicates that while there is significant retinal damage, the central vision area remains unaffected, which is a critical distinction in treatment planning.
Detailed retinal examination findings, including presence or absence of macular edema and treatment plans.
Patients presenting with vision changes, routine diabetic eye exams, and follow-up after laser treatment.
Ensure clarity in documenting the type of retinopathy and any interventions performed.
Comprehensive diabetes management records, including HbA1c levels and treatment regimens.
Management of diabetes with complications, routine follow-ups, and adjustments in insulin therapy.
Document the patient's overall diabetes control and any referrals to ophthalmology.
Used for treatment of proliferative diabetic retinopathy.
Document the indication for laser treatment and the specific eye treated.
Ophthalmology must ensure that the procedure is linked to the correct diagnosis.
Specifying the absence of macular edema is crucial as it affects treatment options and prognosis. It indicates that while there is significant retinal damage, the central vision area remains unaffected, which is important for management strategies.
